Lannett to buy UCB unit to boost specialty generic ***** portfolio
 

Lannett to buy UCB unit to boost specialty generic ***** portfolio
(Reuters) - Lannett Co Inc said it would buy Kremers Urban Pharmaceuticals Inc, a U.S. unit of Belgian drugmaker UCB SA , for $1.23 billion to expand its specialty generic ***** portfolio.http://feeds.feedburner.com/~ff/news...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/news...Is:V_sGLiPBpWU http://feeds.feedburner.com/~ff/news...Is:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/news/...~4/uaZi-qLmec0